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Abstract
Hypofractionated radiosurgery either through frame or image guidance has emerged
as the most important area of research and development for intracranial and extracra‐
nial radiosurgery. In this chapter, we focused on discussions of three state-of-the-art
platforms: Frame- and Image-Guided Gamma Knife, Robotic X-Band Cykerknife, and
Flattening-Filter-Free intensity-modulated S-band medical linear accelerators. Practical
principles with detailed workflow and clinical implementations are presented in a
systematic approach. With rapid evolvement of both hardware and software in the
realm of delivering hypofractionated radiosurgery, this chapter aims to offer a reader
physical  clarity  on  judging  and  balancing  of  achieving  high-precision  and  high-
quality treatments with practical examples and guidelines on intracranial applications.
Keywords: hypofractionation, radiosurgery, Gamma Knife, Cyberknife, flattening
filter free, linear accelerator
1. Hypofractionated Gamma Knife radiosurgery
The genesis of radiosurgery dated to the late 1940s when Swedish neurosurgeon Professor Dr.
Lars Leksell pioneered the first stereotactic radiosurgery (SRS) device called Gamma Knife. The
basic concept of radiosurgery (e.g., performing surgery without a scapel but with invisible
photon rays) was revolutionary at the time, and it took several trials for Leksell to convince his
peers and published his first paper on the device [1].
A key turning point in worldwide utilization of Gamma Knife radiosurgery (GKSRS) was its
first North American installation at the University of Pittsburgh in 1987 [2]. Gradually and
steadily, GKSRS has been demonstrated to be a highly successful modality in managing many
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benign and malignant indications [3–9]. However, due to the finite beam collimation size
(maximum beam collimator diameter of 1.6–1.8 cm) and manual setups of individual patients,
majority of the targets treated are relatively small lesions (e.g., <4 or 5 cm in maximum target
dimension) and are generally treated in a single fraction [6, 9].
In 2006, GKSRS system underwent a redesign from ground up and the Leksell Gamma Knife
Perfexion (PFX) was introduced in 2006, first in France, the UK, and then in the USA [10–13].
The key features of the PFX included an automatic submillimeter patient-positioning couch
and a universal collimator system automatically aligns the radiation beamlets for variable
collimation sizes. These new improvements physically eliminated manual setups of the early
GKSRS models. As a result, GKSRS treatment delivery has become a turnkey solution and a
large number of isocenters to be readily delivered with the minimum treatment effort. This
greatly expanded the traditional GKSRS capability of treating large targets with a high number
of isocenters.
With the advent of imaging guidance, the most recently developed Leksell Gamma Knife Icon
(LGKI) has enabled repeatable patient setups without an invasive immobilization of an
invasive metal frame, thus ushered in a new era of delivering hypofractionated GKSRS
without number of isocenter restrictions. The general practice principles of GKSRS and its
associated technical features of LGKI are described in detail in this section.
1.1. General physical principles
Unlike traditional C-arm radiation therapy delivery where a single source of radiation is
employed and the radiation beams are delivered one beam after another in a sequential
manner, GKSRS was designed from the start to employ hundreds of radiation beams to cross-
fire in a simultaneous manner. In general, radiosurgical treatment delivery can be classified
into four-type treatment delivery paradigms: (1) immobilize patient and radiation beams
together, (2) mobilize patient and radiation beams together, (3) immobilize patient but
mobilize radiation beams, and (4) mobilize patient but immobilize radiation beams.
The first and second types of treatment delivery are uncommon and employed primarily in
specialized treatments such as ocular melanoma treatment, etc. Most of modern linac-based
radiosurgical treatments employed the third type of delivery, where the patient or the
treatment target was typically immobilized through various means, and radiation beams are
delivered in sequence with the general assumption that patient’s or target’s position remained
unchanged during the beam irradiation.
In contrast, GKSRS is a classic example of employing the fourth type of delivery, that is, all the
radiation beams were fixed and the patient’s positioning are adjusted from time to time to
allow radiation dose delivered to different spots inside a 3D target volume. As a result, the
overall precision involved in the treatment for GKSRS is largely governed by the positioning
accuracy of the patient itself. The latest GKSRS PFX and Icon device have further improved
general accuracy of GKSRS by employing fully digitally controlled patient positioning system
(PPS) and patient surveillance system (PSS). With frame-based as well as latest infrared
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marker-based patient positioning monitoring capability, the system has been updated to detect
mechanical shifts in the range of a few microns.
Figure 1 shows the latest GKSRS device, that is, the PFX and LGKI unit. Unlike previous GKSRS
models, both PFX and LGKI employ a combination of the third and the fourth delivery
paradigm as discussed above to achieve unmatched dose painting in the treatment planning
process (the details of such a capability are described in the following section). In another word,
once the patient is immobilized and aligned based on a pre-prescribed fixed position, the
radiation beams become changeable while the patient is in position through a unique universal
collimator system and a fully automatic couch patient positioning system as shown in the panel
(a) of Figure 1. The details of the system components of the PFX and LGKI for hypofractionated
GKSRS are described in the following paragraphs.
Figure 1. (a) The Leksell Gamma Knife Perfexion (PFX) units and (b) Lekesell Gamma Knife Icon (LGKI) unit. Both
systems possessed the same radiation generation mechanism through 192 Co-60 beams and a tungsten universal colli‐
mator behind a shield door as shown in Panel (a). The key difference between the two systems is the addition of a
stereostatic cone-beam CT arm mounted for the LGKI unit as shown in Panel (b).
In summary, current GKSRS delivery through either PFX or LGI has enabled a combination
of treatment delivery paradigms that successfully integrated mechanisms of precision patient
immobilization (either with relocatable frame of PFX or with imaging-guided masking system
of LGI) and the precision radiation beam alignment techniques to deliver adaptive hypofrac‐
tional radiosurgical treatments. In the words of the Professor Dr. Lars Leksell, inventor of
Gamma Knife: “The tools used by the surgeons must be adapted to the task and where the
human brain is concerned they cannot be too refined”. This is certainly the case for hypofrac‐
tionated brain radiosurgery.
1.2. System design, hardware and work flow
One of the hallmarks of GKSRS was its Leksell G-frame system for immobilization of the skull
of a patient. Besides being sturdy in securing and immobilizing the patient’s skull for beam
referencing, a major physical advantage of the frame is its elimination of rotational shifts
required in patient setups. In another word, any point in the space can be readily reached with
simple translational shifts along x-, y-, and z-directions once the frame has established its
Cartesian coordinate system. However, due to invasive nature of the frame and current
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medical reimbursement rules in the USA, the frame-based GKSRS treatment was primarily
limited to the single fraction GKSRS.
Recognizing the restrictions with the metal frame for delivering hypofractionated treatments,
a vacuum-assisted relocatable frame system, that is, GK eXtend [14–17] was introduced shortly
after the introduction of the PFX system in 2006. Figure 2 illustrated the construction of such
a relocatable frame system in actual clinical practice.
Figure 2. Illustration of the GKSRS relocatable eXtend frame system shows: (a) the components of the customized eX‐
tend frame with bite-block molded and docked onto the PFX unit and (b) the actual patient using the eXtend frame
prior to the treatment delivery.
The relocatable frame as shown in the figure was adapted and improved over the conventional
radiation therapy bite-block immobilization device. One major improvement is the use of
vacuum assistance and saliva control cups that allow the bite-block to be anchored unto the
hard palate in the patient’s mouth. Together with vacuum cushion of the headrest (Fig‐
ure 3a) supporting the back of the patient’s skull, the patient’s head immobilized with respect
to the two lateral posts that is attached to the couch.
Evidently, the accuracy of such a relocatable frame depends on the positioning repeatability
of the patient. Figure 3b shows the plastic template box attached to the superior of the patient
head for such a purpose. The plastic template box was used to check the repeatability of the
frame setup through the traditional dip-stick measurements, where the skull surface of
variable points was measured before the treatment to ensure correct frame setups. In the case
of eXtend frame showing in Figure 3b, such measurements were manually conducted through
a calibrated digital probe, and measurement results were compared with the reference values
taken at the time of the patient’s CT scanning. An illustration of the probe measurement in
conjunction with the patient setup of Figure 2 is shown in Figure 4.
Several studies utilizing the PFX eXtend system have reported in-phantom as well as in-patient
accuracy of 1 mm or less [16, 17]. One study primarily investigated the whole-procedural
accuracy of the hypofractionated GKSRS treatments through the generalized end-to-end
Winston-Lutz measurements as well as intrafractional patient data analysis [16]. The 3D
radiological setup accuracy was determined to be 0.69 ± 0.73 mm (1σ) from a series of n = 58
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treatment session, and the mean 90% confidence level range of uncertainties was found to be
0.55, 0.78, and 0.72 mm along the x-, y-, and z-axis, respectively.
Figure 3. Illustration of the digital probe measurements for the hypofractionated GKSRS setups with the relocatable
eXtend frame system on the PFX unit shows: (a) the hand-held digital probe ruler with the actual patient setups and
(b) the measurement result of the probe at one template position. The difference displayed between the reference
measurement and the actual measurement in (b) was in the unit of millimeter.
Figure 4. Major add-on system components of the Gamam Knife Icon (GKI) compared to the PFX include (1) a patient
masking immobilization system (upper insert); (2) an on-line 3D imaging capability with stereotactic calibrated cone-
beam CT device; and (3) a high-definition patient motion monitoring detector and feedback control system.
Evidently, the whole-procedural accuracy of these measurements included the positioning
accuracy by the full couch motions. Given that multiple shots are typically used for hypofrac‐
tionated treatments of relatively large lesions, the wear-and-tear of the couch in performing
thousands of the patient setups may become a concern to ensure submillimeter accuracy. To
investigate such problem, the central positioning as well as off-center couch positioning
consistency was investigated through the so-called “picket fence” testing for a high-volume
treatment center [18]. The study found an overall accuracy consistency of 0.03 ± 0.24 (2σ) mm.
Such a value matched excellently with the manufacturer’s mechanical specification of 0.35 mm
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even after repeated use of completing >1000 treatment cases. Based on the results of the study,
the overall 3D vector accuracy was predominantly contributed by patient-specific rather than
hardware-related in hypofractionated GKSRS treatments with the relocatable eXtend frame
system.
Of note, patients to be treated with eXtend frame system need to be carefully selected before
applying the relocatable eXtend frame system, specifically in regard to the performance status,
gum health, and teeth integrity. With a team of experienced radiation therapy, users familiar
with fabrication of conventional radiation therapy bite-blocks and managing patient’s oral
hygiene, hypofractionated GKSRS treatment with the PFX eXtend frame was an excellent
option for expanding the traditional single-fractional GKSRS program.
Nearly a decade from the initial introduction of GK PFX system in 2006, US Food and Drug
Administration and Nuclear Regulatory Commission have recently approved the image-
guided Gamma Knife Icon (GKI) system. The GKI system is an integration of the PFX system
with a 3D CBCT and a high-definition patient motion management system as shown in
Figure 5. The 3D CBCT was designed to correct both translational and rotational shifts
encountered during the initial patient setups when immobilized with the mask system. The
patient motion management system monitors the patient’s head positioning during the
treatment delivery through a reflective marker placed on the patient’s nose bridge in reference
to the two lateral black post points as shown in the insert of Figure 5.
Figure 5. Axial dose distributions of a hypofractionated GKSRS treatment as planned with Leksell Gamma Plan (LGP
version 10.2) for PFX or GKI treatments. Note the sharp dose fall-off along the posterior portion of the brainstem for
maximum dose sparing.
The hypofractionated GKSRS workflow is similar among the eXtend frame system and the
mask-based GKI system, where patient will undergo traditional MR and CT scans before the
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treatment. However, the available of online 3D imaging guidance as offered by the GKI system
allows the patient to be scanned without a tertiary frame, thus artifacts or susceptibility
uncertainties introduced by these devices are eliminated from the workflow. In essence, on-
device 3D CBCT serves not only as a “virtual” stereotactic frame but also as on-treatment
patient positioning detection system.
Another important feature of GKI is its online dose recalculation and/or dose adaption
workflow based on the 3D positioning as detected in vivo. In another word, once the patient
position is measured by the CBCT, the 3D dose distribution based on the live patient setups
(i.e., target location) will be recalculated and reference to the original treatment planning
generated dose distributions. The attending physician and authorized medical physicist
(AMP) for the treatment are afforded the opportunity to review or revise and approve the
treatment plan before initiation of actual treatment delivery. The unique dose sculpting
capability of the Leksell Gamma Plan (LGP) allows such a process to be an efficient and robust
procedure.
1.3. Treatment planning and dosimetric evaluation
Compared to the early GKSRS treatment delivery, a user quickly would notice a major
paradigm shift in planning PFX or GKI-based treatment delivery versus the previous Gamma
Knife models. Traditionally, each isocenter or called a “shot” in the GKSRS is set and verified
either manually or semi-manually through a tertiary add-on manipulator. As a result, using
fewer numbers of shots to accomplish a treatment plan is desirable to ensure treatment delivery
efficiency and patient comfort. Therefore, a user tends to optimize a treatment plan with
mindset of minimizing the total number of shots as much as possible.
With the automatic full couch positioning system as in PFX or GKI, delivering multiple shots
has become a turnkey solution. This has significantly shifted treatment-planning practices and
in essence rendered hypofractionated treatment of relatively large or complex lesions a logical
fit for planning with the PFX or GKI system. Without repeating many excellent reviews on
classical GKSRS treatment planning techniques, we here focus on specific issues related to the
hypofractionted treatment planning.
Figure 6 illustrated a 3D axial isodose distribution of a large hypofractionated GKSRS
meningioma case, where 25 Gy in five fractions were prescribed to 50% of the maximum dose
inside the target. Note the significant sharper dose fall-off along the brainstem surface area for
the lesion as created by the planner when applying a relatively high number of shots (n = 28)
and liberal use of the smallest collimator shots (i.e., 4 mm in nominal beam diameter) along
the brainstem surface area.
Since single-session dose of 5 Gy is significantly lower than the traditional GKSRS of 15–20 Gy
per session, the total number of shots can be used is therefore largely constrained by the
minimum amount of radiation that can be delivered per shot. For example, if the maximum
dose rate for the given treatment session is 3 Gy per minute, then 0.3 Gy would be minimum
dose required per shot within the mechanical timer accuracy of 0.1 min per shot. As a result,
the contribution from each shot should be at least 0.3 Gy for this case, thus limiting the total
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number of shots may be used for delivering such a treatment. This is a unique phenomenon
for hypofractionated GKSRS.
Figure 6. The Cyberknife VSI system installed in a clinical setting. Note the two X-ray tubes mounted on the ceiling
and the X-ray detectors that are placed beneath the floor of the treatment vault for stereotactic imaging and on-line
tracking.
Evaluation of hypofractionated GKSRS treatment plans as illustrated in Figure 6 is identical
to the conventional GKSR, that is, dosimetric treatment planning indices such as Paddick
conformity index (PCI) [19] and gradient index (GI) [20] similarly apply to single as well as
hypofractionated GKSRS.
In summary, the PCI is defined as PCI = (TIV)2/(PIV × TV), where TIV is the volume of the
target falls inside 100% of the prescription isodose surface, PIV is the total 100% prescription
isodose volume, and TV is the total target volume. In parallel, the GI is defined as GI = PIV50/
PIV, where PIV50 is the total isodose volume enclosed by 50% of the prescription dose.
From the definitions of PCI and GI of the above, PCI is a direct measurement of how well the
prescription isodose volume match or “conform” to the target volume, and GI is the measure
of how steep the planned dose distribution falls beyond the prescription isodose surface.
Studies have been carried out to investigate the best possible dose gradient that can be achieved
for general GKSRS, and an empirical power law was found to describe such a dose fall-off near
perfectly yielding high linear correlation of > 90% [12, 21].
In the context of hypofractionated treatment delivery, it is worth noting that PIV50 can be
easily replaced with PIV30, PIV40, PIV60, etc. (e.g., 30, 40, 60, etc.) prescription isodose volumes
to expand the definition of GI and allow detailed survey of the isodose dose effects associated
with hypofractionated treatments. Unlike single fractional GKSRS delivery where peripheral
isodose volumes around PIV50 such as the 10-Gy or 12-Gy isodose volumes have been reported
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to surrogated the treatment complications such as symptomatic radiation necrosis rate,
relevant isodose volumes for variable fractionation schemes such as 3–5 fractions have yet been
established. Therefore, a user need to be careful in examining the peripheral isodose fall-off
measures such as the PIV30, PIV40 or PIV60, etc. for all treatments until future clinical data
and guidelines become available.
1.4. Future direction and developments
With the advent of GKI, hypofractionated GKSRS treatments expected to expand rapidly in
the years ahead. Initial studies have shown excellent precision as well as robustness for patient
positioning correction capability that rival frame-based treatment deliveries. With reduced
dose for each hypofractionated treatment session such as 5–8 Gy and integrated stereo-CBCT
treatment setups with direct coordinates adaption, the overall treatment delivery time with
GKI would be expected to be 30 min or less that making it match well with other treatment
modalities.
Several studies have indicated superior dose sculpting capabilities of PFX and GKI versus early
GK SRS models [11]. Further treatment planning studies have also suggested equivalency of
linac-based delivery with an early GK model [22]. Such a result supports the general finding
of superiority of PFX and GI versus the linac-based treatment in sparing normal brain tissues
[23–25]. These studies have clearly fortified the leading role of GKSRS in performing intracra‐
nial hypofractionated SRS.
However, it is worth mentioning several ongoing efforts in continually improving the
dosimetric capabilities of GKSRS. One study has proposed the notion of dynamic GKSR
delivery, where the whole treatment can be delivered through single path motion (i.e., the
beam is always on during a treatment) in contrast to the step-and-shoot type of delivery [26].
One major improvement in the dosimetric properties noted was the significant improvements
in the dose homogeneity within the target as well as some improvements in the peripheral
dose fall-off, a likely contribution from the increased number of the beams associated with the
treatment delivery.
Another study leveraging the power of sector beam mixing has proposed the concept of
simultaneous intensity modulation for GKSRS [27]. In the mode of such a delivery, the intensity
levels in 2π arrangement become fully variable from either zero (closed sector beam) to unity
(open sector beam) during each shot delivery. It was found that significant normal tissue
sparing improvements achieved by adding the sector intensity modulation for complex
treatment cases such as epilepsy and for large lesion treatments involving a high number of
isocenters. The latter of which is clearly relevant for the hypofractionated GKSRS. One key
advantage noted with sector-beam intensity modulation is that the total beam-on time is
equivalent to the traditional nonmodulated treatment deliveries thus making the approach
clinically ready with the current PFX and GKI hardware design. Ongoing and further studies
will determine whether dosimetric improvements as discussed above would translate into
clear clinical advantages, especially in the developments of hypofractionated GKSRS.
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2. Hypofractionated robotic CyberKnife radiosurgery
The CyberKnife (CK) is an image-guided, frameless, robotic radiosurgery system invented by
John Adler and his team in the late 1980s [28, 29]. Unlike in the Gamma Knife system where
Gamma rays from Co-60 decay are used for treatments, the CyberKnife system uses X-rays
generated from a linear accelerator for radiation treatments. While the system received FDA
clearance to treat head and neck, and upper spine lesions in 1999, in 2001, clearance was given
to treat lesions located anywhere in the body. Therefore, the current system can be used for
both intracranial and extracranial (spine, lung, liver, pelvis, etc.) radiation treatments. The CK
system is not only an integrated unit consisting of treatment planning, imaging, and delivery,
but also unique in its ability to continuously track, detect, and correct for both tumor and
patient motion during treatment.
2.1. System descriptions and working principle
CyberKnife treatments are delivered through a motorized robotic manipulator (KUKA robot)
that is attached to a lightweight X-band linear accelerator (linac) (Figure 3). The robotic
manipulator allows for six degrees of freedom in positioning the radiation source, and allows
for noncoplanar, nonisocentric beam delivery. The linac generates 6 MV photons, at a nominal
dose rate of up to 1000 cGy/min. The manipulator is programmed to move within a fixed,
predetermined workspace, and positions the radiation source at pre-assigned points within
this workspace referred to as “nodes”. At each node, the linac can deliver radiation from
multiple beam angles [30]. Dose is delivered from “paths,” which comprise of a series of nodes,
determined during treatment planning. During treatment delivery, the manipulator moves
the accelerator from node to node in sequence and delivers dose at those nodes selected during
planning. The treatment path adopted by the robotic manipulator is dependent on the target
location and patient anatomy as specified during treatment planning.
The radiation is collimated using either 12 interchangeable tungsten cones (known as “fixed”
collimators), or the IrisTM (a variable aperture collimator [31]), both with aperture diameters
ranging from 5 to 60 mm at a SAD of 800 mm. The IrisTM is made of two offset banks of six
tungsten segments each, which combine to create dodecahedral apertures. With the Iris, the
robot traverses the treatment path only once while delivering radiation from multiple
collimating apertures at the chosen node position. In comparison, with the CK fixed cone
system, the robot has to traverse the treatment path separately for each fixed cone size used
for the treatment. Therefore, the Iris allows the use of multiple collimating apertures for a given
treatment without drastically increasing treatment time. The newly released CK M6 platform,
available for clinical use today, is additionally equipped with a multi leaf collimating (MLC)
system that provides further potential for improved efficiency in the treatment delivery. This
MLC system (CK InCise MLC system, Accuray Inc.) consists of 41 tungsten leaf pairs of 90 mm
height and 2.5mm thickness at 800 mm SAD, and allows for a maximum field size of 120 (in
the leaf motion direction) × 100 mm at 800 mm SAD. Leaf motion allows for 100% over-travel
and full leaf inter-digitation, and has an average (intra-leaf, inter-leaf, and leaf tip) transmission
of <0.3% [32].
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The tracking volume (or the target volume itself) is stereotactically localized using orthogonal
kV X-ray images. X-rays in the diagnostic energy range are generated from two X-ray sources
that are attached to the treatment room ceiling. The X-rays exiting the patient are detected by
amorphous silicon flat panel detectors, which are embedded beneath the floor. The imaging
center, or the point in space at which these imaging beams intersect, is referred to as the “align
center”. The geometry of the imaging system is such that the patient is imaged at a 45° angle.
The high-resolution digital X-ray images obtained during patient setup and treatment are
automatically registered to a set of digitally reconstructed radiographs (DRRs) generated from
the treatment planning CT. The difference in patient positioning from simulation to treatment
in the three translation and rotational directions are calculated based on this 2D–2D registra‐
tion. During treatment, the patient is imaged at an imaging frequency that can be specified by
the operator. The imaging frequency can be set between 15 and 150 sec, and it is common to
image the patient at time intervals of 30–60 sec in the case of brain treatments. During treatment
delivery, the robotic manipulator compensates for the differences seen in the patient, or target
position, by redirecting the radiation beam to the actual target position in near-real time.
2.2. Treatment simulation and inverse planning
Proper patient simulation is critical to ensure an accurate treatment delivery. While it is
imperative in radiation therapy in general, to achieve a patient setup that is both easily
reproducible and comfortable for the patient, for CK treatments the patient setup should in
addition adhere to specific patient safety zone requirements. The CK system consists of two
virtual safety zones, named the “fixed safety zone” and the “dynamic safety zone”. These
safety zones are designed as safety mechanisms to prevent robot collisions with the patient.
The fixed safety zone is based on the imaging center and varies in dimension depending on
the treatment site (i.e., head vs. body). The dynamic safety zone is located within the fixed
safety zone [30, 33]. It includes all of the patient body and varies in size based on the individual
patient’s size (small, medium, and large) as specified by the therapist.
For brain treatments, custom-made head masks are used to immobilize the patient. An
appropriate headrest is chosen so that the patient’s neck is in a comfortable position. In
particular, hyperextended or flexed neck positions are discouraged, as treatment times can be
as long as 30 min for a typical brain treatment. The treatment times could be even longer for
multiple brain metastasis treatments, based on the number of lesions, lesion size, and pre‐
scription dose to each. The patient’s arms and knees should be placed in compliance with the
patient safety zone requirements discussed above.
CT simulation is performed with the patient in the supine position. A contiguous, no gap CT
scan is obtained with a 1–1.5 mm slice thickness. The slice thickness is important as thinner
slices generate better quality DRRs improving the tracking accuracy [34]. The CT field-of-view
should be reasonable (typically 30 cm) and not unnecessarily large for improved image quality.
The scan should be centered on the target and includes the entire patient head as the tracking
algorithm for brain treatments is based on the patient’s skull features. The primary CT used
for treatment planning should be a noncontrast CT as contrast in the scan may impact dose
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calculation and tracking accuracy. If a contrast CT is needed, the contrast CT can be imported
into the planning system as a secondary image set.
2.2.1. Image registration and structure contouring
For brain CK treatments, MR imaging is used for target delineation because MR provides better
soft tissue visualization compared to CT. Certain critical structures such as the brainstem and
chiasm are also better visualized on MR. Because dose calculation for treatment planning is
based on CT, the MR images are imported into the planning system as secondary image set
and coregistered with the primary CT data set. Several image registration options are available
within the CK treatment planning software. For most brain cases, the automatic registration
feature is commonly used, and the user can specify the region of interest for the auto-regis‐
tration. This algorithm uses intensity values based on mutual information. In addition, a
semiautomatic point based, and manual registration methods are also available. Once target
contouring is complete, critical structures are delineated. MR images are then used to define
certain critical structures such as the brainstem and chiasm, whereas the some other structures
such as the optic nerves and cochlea can be better defined based on the planning CT.
The difficulty level of treatment planning for brain lesions can vary depending on the target
location and proximity to critical structures such as the brain stem and optic structures. For
those cases in which the critical structures are in close proximity to the target volume, planning
risk volumes (PRVs) may be generated by expanding those critical structures by ~2–3 mm and
by ensuring that these PRV volumes are well within their dose tolerance during the treatment
planning process. Another option is to generate a new planning target volume (PTV) by
subtracting the expanded critical structure from the original PTV. The treatment plan can then
be optimized using this “modified PTV” to confine the portion of the PTV receiving less than
the prescription dose to the PTV-critical structure interface. By targeting the radiation beams
to the edges of the “modified PTV” instead of the original PTV by applying beam collimators
to the modified PTV, a sharper dose gradient can be created at the PTV-critical structure
interface, allowing for better sparing of the critical structure while maintaining good dose
coverage of the target volume. The collimator size chosen for beam generation is dependent
on the target dimensions, complexity and location. Either the fixed or the IrisTM collimating
systems can be used. However, with the fixed cones, the number of cone sizes is typically
limited to three to reduce treatment time, because as mentioned previously in this chapter
during treatment delivery, the robot has to traverse the treatment path with each cone
separately. This limitation in the number of aperture diameters to be selected is not a concern
when using the IrisTM, as the robot can change apertures at a given beam position during single
treatment path traversal. The smallest IrisTM apertures (i.e., 5 and 7.5 mm) are typically avoided
during treatment planning as small differences in field size can result in significantly large
differences in beam output [35, 36].
Once the user selects the beam apertures, a set of a few thousand-candidate beams is generated.
These beams are defined based on the node positions, target location, and collimators chosen.
Either isocentric targeting or conformal targeting can be chosen for planning CK brain cases.
In isocentric targeting, all beams point toward a single user specified target location within the
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tumor, and there is only one beam per node position. Isocentric planning is mostly used for
simple cases, where the lesion is nearly spherical and not adjacent to critical structures. With
conformal targeting, beams target multiple locations within the tumor. The target points are
randomly distributed over the tumor perimeter, and multiple beams per node position are
utilized. A typical plan consists of over a hundred nonisocentric, noncoplanar beams
(Figure 7b) in the conformal targeting scenario. Conformal targeting is useful for complicated
brain cases. Beam entry through the eyes is typically prohibited.
Figure 7. (a) Shell structures (a total of five shown here) generated surrounding the planning target volume to improve
dose conformity and produce sharp dose gradients outside of the target. (b) A 3D representation of the beam angles
used for an example CK brain treatment in which over a hundred nonisocentric, noncoplanar beams are being used. (c)
Isodose distribution for an example CK brain treatment in which the planning target volume abuts the brain stem. The
dose distribution is displayed on the MR images used for target delineation.
The user can also constrain the total number of monitor units (MUs) to be used for a plan, as
well as specify the monitor units that should be used per node and per beam. Constraining
the contribution of monitor units (MUs) from a given beam/node allows a wider distribution
(or spread in beam angles) of nonisocentric, noncoplanar beams, and limits a high dose
contribution from a single direction. This helps minimize “dose fingers” (high dose (typically
>40–50% of the prescription dose) streaks/areas spanning from outside of the target volume
toward the skin, that are shaped similar to a finger) and dose hot spots in normal tissue. The
maximum MUs per node were set to be slightly higher than the maximum MUs per beam to
allow for multiple beams per node. For a typical brain plan, the total MUs are ~5–10 times the
prescription dose.
The dose distribution is optimized by adjusting the weighting of the beam MUs in the
candidate beam set generated based on the user specified dose objectives/constraints, to
minimize a linear cost function. Sequential optimization [37] is commonly used in treatment
planning, where different optimization objectives such as target coverage, conformity, and
dose constraints to critical structures are addressed sequentially in a user-specified order. The
optimization moves from one step to the next, only when those goals set by the planner are
met within user-specified relaxation criteria. This allows the user to prioritize goals (i.e., target
coverage vs. critical structure sparing) in a clinically significant patient specific manner.
MultiPlanTM (the CyberKnife treatment planning software) further allows for the generation
of multiple shell structures of varying radii surrounding the target volume (Figure 7a). Dose
constraints applied to these shells can be manipulated to achieve a highly conformal plan and
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to guide and tighten the dose fall of outside of the target volume. In addition, beam reduction
and time reduction tools are available to the planner to assess and improve plan efficiency
without compromising plan quality.
The CK treatment planning system provides two dose calculation algorithms: (1) Ray-tracing
and (2) Monte Carlo. Ray-tracing uses the effective path length to determine dose deposition
based on tissue heterogeneities, and is based on a pencil beam approach in which a single beam
is considered to constitute of many single rays [33]. However, photon scatter and lateral
electron scatter in heterogeneous media are not correctly accounted for with Ray-tracking as
is with Monte Carlo. This results in substantial inaccuracies in dose calculation at the interface
of tissues of different densities and for those lesions that are located within low-density (i.e.,
lung, sinuses) and high-density (i.e., bone) tissues [38]. For example, for lung cases, using Ray-
tracing for dose calculation can result in 8–11% differences compared to that calculated with
Monte Carlo [38]. For brain lesions that are not adjacent to, or in, air/bone, the differences in
the plans calculated using Ray-tracing compared to Monte Carlo are clinically insignificant,
with the differences in maximum dose to the critical structures and tumor coverage generally
found to be <5% between the two calculation methods [39]. However, for those lesions that are
located in/adjacent to the sinus cavity or bony anatomy, dose calculation with Monte Carlo
may provide more accurate results. The Monte Carlo algorithm uses theoretical simulation
and experimental results to calculate dose deposition from each particle traveling through
tissue, considering its interactions with other particles. The Monte Carlo platform specifically
employed within the CK treatment planning system uses a single source model, which
simulates photon interactions with media for a variety of photon energies. The travel paths of
the secondary electrons generated by the interaction of photons with tissue are further
considered. Dose deposition by these charged particles is calculated considering tissue density
differences and electron stopping powers [38].
2.2.2. Typical treatment planning dose volume constraints
Typical fractionation schemes for CK brain treatments are 25 or 30 Gy in five fractions. Single
and three fraction dose schemes are also sometimes used. Dose constraints to critical structures
are mainly based on those recommend by AAPMs Task Group Report [40] as given in Table 1.
Single fraction Three fractions Five fractions















Optic pathway <0.2 cc 8 10 15.3 17.4 23 25
Cochlea 9 17.1 25
Brainstem (not
medulla)
<0.5 cc 10 15 18 23.1 23 31
Spinal cord and
medulla
<0.35 cc 10 14 18 21.9 23 30
<1.2 cc 7 12.3 14.5
Table 1. Dose constraints for hypofractionated brain treatments as recommended by AAPMs Task Group 101.
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Figure 7c shows an example of a complicated brain CK plan in which the target volume abuts
the brainstem. A prescription dose of 25 Gy was prescribed to the planning target volume in
five fractions in this particular case. Dose was prescribed to the 70% isodose line. The brain
stem maximum dose (0.035 cc) for this particular case was kept below 22 Gy. The optic chiasm
maximum dose was <9 Gy and the optic nerve maximum dose was ~10 Gy. The gradient index
and the conformality index (nCI) for this particular plan was 2.92 and 1.13, respectively. The
dose distribution within the target volume is highly heterogeneous as is commonly the case
for CK plans, because typical prescription isodose lines for brain treatments vary between 60
and 75%. However, with the CyberKnife, the planner can guide the optimization to achieve a
plan prescribing to a wide range of isodoselines. Therefore, CK plans can be tailored to achieve
plans similar to Gamma Knife plans (by optimizing the plan such that the prescription isodose
is ~50%) or linac based SRS/SBRT plans (by optimizing the plan such that the prescription
isodose is between 70 and 80%).
2.3. Clinical studies – hypofractionated brain treatments
Several clinical investigations have reported on the safety and efficacy of hypofractionated CK
brain treatments. One such study [41] looking at CK treatments for large brain metastases
delivering 30–41 Gy in 3–5 fractions, reported a crude local tumor control (LTC) rate of 86.8%.
The estimated LTC rates at 12 and 24 months were 87 and 65.2%. The median overall survival
and progression-free survival rates were 16 and 11 months, respectively. Patient performance
status and preoperative neurologic deficits reportedly improved in 57.1 and 70.6%, respec‐
tively. Another study [42] evaluating the efficacy and toxicity of 5-fraction CK radiotherapy
in patients with large brain metastases in critical areas, demonstrated that a high rate of local
tumor control and low rate of complications are achievable. They report a local tumor control
rate of 92.9% during a median follow-up of 8 months and report that neurological manifesta‐
tions improved in 50.9% of the patients.
2.4. Intrafractional monitoring and treatment delivery
A 6D Skull Tracking is the tracking method used for CK brain treatments. This method is
frameless and uses the bony anatomy of the skull obtained from 2D X-ray imaging for patient
set up and for determining and correcting for patient motion during treatment delivery. This
tracking method can be used for intracranial, head and neck, and certain upper spine (C1, C2)
treatments. The algorithm assumes a fixed relationship, between the target, the “align center”
and the bony anatomy of the skull. The “align center” (also referred to as the imaging center)
is user defined during treatment planning. For brain treatments, the “align center” is chosen
such that the superior and anterior parts of the skull are ~10–15 mm from the edge of the
imaging field-of-view (Figure 8).
Prior to treatment start, the patient is immobilized and positioned as during simulation. Patient
setup is carried out through a motorized couch, which has either 5 (standard couch) or 6
(RoboCouchTM) degrees of freedom. A pair of X-ray images is taken to make gross adjustments
to the patient position, which can then be fine-tuned using automatic couch movements.
Correct positioning is confirmed by comparing the live X-ray images to DRRs from the
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treatment planning CT. The algorithm correlates the live X-ray images with the DRRs based
on pixel similarity criteria. X-ray technique (kV, mAs and exposure time) needs to be optimized
by using parameters provided by the software showing differences in the estimated align
center position based on each image along the common superior/inferior axis, similarity of
overall image intensity between the live images and the DRRs, and the presence of external
objects in the X-ray image that are not on the DRR.
Figure 8. An example of how the “align center” or the imaging center is specified during treatment planning for an
example CK brain treatment. The “align center” is chosen such that the superior and anterior parts of the skull on the
DRRs are ~10–15 mm from the edge of the imaging field-of-view. The bottom portion displays the placement of the
cross hairs on the planning CT images to achieve the appropriate placement of the skull on the DRR images as shown
on the top panel.
Once the beam is on for treatment, orthogonal X-rays are intermittently taken (at time intervals
of 30–60 sec (lower imaging interval can be chosen on a case-by-case basis). These images are
automatically registered to the DRRs derived from the treatment planning CT. Unique to the
CKS, the robotic manipulator uses this near real-time target position information to retarget
the radiation beam to the current target position, thus eliminating the need for patient
repositioning. The robot can automatically correct for translations up to 10 mm, and rotations
of 1, 1, and 3° for the roll, yaw and pitch, respectively.
Submillimeter accuracy is achievable through 6D Skull Tracking. A recent study [43] used log
files generated by the CKS, as well as the actual treatment parameters from each procedure to
investigate the mechanical uncertainty in beam localization over a time period of approxi‐
mately 1 year. They further evaluated patterns of patient movement during brain CK treat‐
ments. They found the mean mechanical uncertainties of CK brain tumor treatments to be 0.07,
0.01, and −0.09 mm in the +inferior/−superior, +left/−right, and +anterior/−posterior directions,
respectively and conclude the CK to be robust in tracking accuracy regardless of patient’s
movement. Their investigations further found a CTV-PTV margin of 2.0 mm to be adequate
in brain tumor treatments for an on-treatment imaging interval of 30–45 sec.
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2.5. Future developments
As mentioned earlier in the chapter, a new CK system equipped with three interchangeable
collimating systems (fixed, Iris, and MLC) is now available for clinical use. This new CK M6
platform has the potential to improve the efficiency of hypofractionated CK treatments and to
further extend the advantages of noncoplanar treatment and real-time tracking to conven‐
tionally fractionated treatment. A recent study [44] assessing the clinical capabilities of the CK-
MLC for hypofractionated brain SBRT demonstrated that treatment plans generated with the
CK-MLC were of equal or better quality compared to clinically approved CK plans using
circular (fixed/IrisTM) collimators. The total monitor units were reduced by 70%, and the
treatment time could be reduced by nearly a half by using the CK-MLC, with an average
treatment time of 17 min compared to 30 min for plans using circular apertures.
3. Hypofractionated S-Band linac-based radiosurgery
In the 1986, Lutz and Winston described “A small field irradiation technique to deliver high
doses of single fraction photon radiation to small, precisely located volumes (0.5–8 cm3) within
the brain”. This marked the beginning of brain SRS with linear accelerators [45, 46]. Now 30
years later, the clinicians have a new generation of radiation therapy machines, which are
designed from the ground up to combine the fast delivery of high dose rate from flattening
filter free (FFF) beam and precise tumor localization with image guided radiotherapy (IGRT),
at their service to push the boundary of SRS with escalated dose protocols and innovative
fraction scheme, limiting side effects and sparing nearby organs at risk. Figure 9 shows the
two modern linear accelerators from Varian (left panel) and Elekta (right panel), respectively.
Figure 9. Two state-of-the-art medical linear accelerators that are capability of high-precision hypofractionated treat‐
ments: left panel shows Edge manufactured from Varian Oncology (Palo Alto, CA) and right panel shows Versa HD
manufactured from Elekta Company (Atlanta, GA).
The newest generation of Linac from Varian, Edge, has X-ray output energies at 6MV (600 MU/
min), 6X FFF mode (1400 MU/min) and 10X FFF mode (2400 MU/min). With gantry and
collimator isocenters accuracy smaller than 0.5 mm radius, gantry, collimator, and couch
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isocenters accuracy smaller than 0.75 mm radius and gantry rotational accuracy smaller than
0.3°, the Edge has the mechanical performance required for SRS. The high definition 120 leaf
MLC, moving at a maximum speed of 2.5 cm/sec, with an extra fine MLC leaf at 2.5 mm in the
central 20 cm and 40 × 22 cm field size, can treat most of the smaller brain tumors.
Versa HD, the latest offering from Elekta, can treat patient with 6 MV-15 MV at 600 MU/min,
6× FFF mode at 1400 MU/min and 10× FFF mode at 2200 MU/min. It also carries the Agility
MLC with 80 MLC pairs at 5 mm width across the full 40 × 40 cm field and a speed up to 3.5
cm/sec. When coupled with dynamic leaf guide, the MLC leaf move at an effective speed of
6.5 cm/sec. Gantry, collimator, and couch isocentricity measurements were within 1, 0.7, and
0.7 mm diameter, respectively [47].
3.1. Beam and patient positioning characteristics
3.1.1. Fast delivery with FFF beam and VMAT
The major drawback of performing SRS with a conventional linear accelerator is the long
delivery time results from the low dose rate. For hypofractionated SRS with 2000 MU per
fraction, the beam on time alone is ~3 min for conventional beams. In 1991, O’Brien PF
presented in his paper that after removed the flattening filter from an AECL Therac-6 linear
accelerator, the dose rate is increased by a factor of 2.75. Now almost all major linacs can operate
in the FFF mode with maximum dose at ~2400 MU/min. Volumetric-modulated arc therapy,
a rotational arc therapy with intensity modulation, achieves highly conformal dose distribu‐
tions with great treatment delivery efficiency and reduced total MU. The VMAT delivery, in
conjunction with the FFF mode, can lead to even greater efficiency in delivery. One study [48]
compared VMAT FFF plan with IMRT flat beams and found that the mean beam-on time
difference was 6.79 min (74.9% decrease); mean treatment delivery time difference was 8.99
min (range: 5.40–13.05 min), a relative improvement of 71.1% (range: 53.4–82.4%) for plans
with high dose fractionations (16–20 Gy/fraction).
3.1.2. Patient positioning with frameless system
With the introduction of on board KV MV imaging and the development of image guided
radiotherapy, frameless intracranial systems become an alternative to the invasive frames used
traditionally to establish the stereotactic coordinates of the targets and ensure the accuracy of
immobilization and positioning such as the Leksell stereotactic frame. The frameless SRS
brings patient convenience and comfort, enables an efficient workflow for hypofractionation,
and makes SRS more available where there is no neurosurgical support. Figure 10 shows the
Leksell frame, Brainlab frameless mask, and Civco’s trUpoint Arch system.
The patient immobilization is ensured by the bite-block and thermoplastic masks. The six
optical marking spheres on top of the Brainlab mask monitored by infrared camera on roof
provide real-time tracking of the departure from the treatment isocenter and information to
determine X-ray imaging frequency. One study has compared four frameless, thermoplastic
mask-based immobilization strategies for inter- and intrafraction patient positioning uncer‐
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tainties [49]. They studied four systems including: (1) head mask with head cushion; (2) head
mask with head cushion and a body immobilizer; (3) head mask and cushion with shoulder
mask and cushion; and (4) same as (3) plus a mouthpiece. The system (4) has a mean inter‐
fraction translational shift of 2.1 (±1.0) mm and intrafraction motion of 0.7 (±0.8) mm, providing
the best accuracy and stability overall.
Figure 10. Left: Leksell frame; middle: Brainlab localization array mask; and right: CIVCO mask.
3.2. Imaging guidance
3.2.1. In-room KV/MV imaging
The comparison of the portal images from electronic portal imaging devices (EPID) with DRR
is the most commonly used patient positioning verification, which can be performed with
either KV on board imager providing higher soft tissue contrast or MV imaging with the
treatment beam when bones or fiducial marks can be used for alignment. Usually an orthog‐
onal image pair is acquired and followed by the automatic shift calculation with the computer
and appropriate correction by the treatment couch. For an improvement of the target visual‐
ization, CBCT can also be performed. As a complementary to the on-linac imaging mainly for
patient initial setup, several commercial product provide intrafraction continuous monitoring
of the patient’s position. The Exac-trac X-ray system consists of two oblique X-ray imagers,
with two floor mounted KV X-ray tubes and two corresponding flat panel detectors on the
ceiling (Figure 11). The system can take images at any gantry or couch angle. With the 6D
fusion option, the system can calculate patient’s position variation in three translational
direction and three rotational directions. Another system to monitor intrafraction movement
is through monitoring patient’s surface features such as the AlignRt system, where a high-
resolution 3D-rendered surface of the patient from the pseudo-random pattern projected on
the patient’s skin, using stereo vision techniques and a triangulation process without any
ionization radiation.
3.2.2. Six degrees-of-freedom couch
With all the advancements of the field of IGRT, a further improvement of patient setup can be
achieved by the new generation of six degrees-of-freedom (6DoF) couch that can correct the
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patient setup in three translational axes and three rotation axes. One group of investigators
performed tests to request a known shift for the 6DoF couch and compared this requested shift
with the actually applied shift by independently measuring the applied shift using different
methods (graph paper, laser, inclinometer, and imaging system) [50]. The study found that the
deviations were −0.01 ± 0.02, 0.01 ± 0.02, and 0.01 ± 0.02 cm for the longitudinal, lateral, and
vertical axes, respectively; 0.03 ± 0.06, −0.04 ± 0.12, and −0.01 ± 0.08° for the three rotational axes
couch rotation, pitch, and roll, respectively.
Figure 11. Left panel: Exactrac X-ray imaging system (Novalis) and right panel: surface-based patient alignment sys‐
tem (AlignRt).
The combination of in-room imaging and robotic couch can achieve high precision in cranial
treatment of immobilized patients. One European group has demonstrated translational
repositioning accuracy of 0.9 ± 0.5 mm for 47 consecutive patients with 372 fractions [51].
3.3. Treatment planning
3.3.1. Cone-based planning
By using cone collimators and multiple intersecting noncoplanar arcs, the linac can deliver
dose distribution similar to that of the Gamma Knife. It produced a tight spherically shaped
high dose region with sharp dose fall-off (Figure 12).
Figure 12. Illustration of a treatment plan case on the Brainlab system.
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3.3.2. VMAT
VMAT offers shorter treatment times that are consistent with the goals of IGRT. It facilitates
sparing proximal normal tissues compared to the fixed aperture techniques and simultane‐
ously treating multiple targets with a single isocenter. One group showed that SRS using
VMAT is a viable alternative to other techniques and enables short treatment times [52].
Another group replanned older model Gamma Knife (GK Model C) treatments of multiple
cranial metastases with multi-arc (MA) and single-arc (SA), single-isocenter VMAT (RapidArc)
in Eclipse [22]. They found that for multiple target SRS, 4-arc VMAT produced clinically
equivalent conformity, dose fall-off, 12 Gy isodose volume, and low isodose spill, and reduced
treatment time compared to an early GK Model C.
4. Summary
In this chapter, we have systematically highlighted three state-of-the-art hypofractionated SRS
modalities in intracranial applications. With rapid maturing in technology and growing
integration of hardware and software in the realm of hypofractionated brain SRS, clinical
applications and consensus guidelines are emerging. Both international and national regional
societies such as the international stereotactic radiosurgery society (ISRS) and American
Association of Physicists in Medicine (AAPM) have initiated joint effort toward developing
clinical practice and consensus guidelines. From the physical point of view, future trends in
the field will continue to move toward significant enhancements in the areas of (1) imaging
guidance, (2) online treatment adaption, and (3) biological tissue effect quantifications for
hypofractionated radiosurgery of large and/or complex brain lesions.
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